Browse the corpus

REFERENCES ACOG Practice Bulletin No. 86: “Viral Hepatitis in Pregnancy,” Obstet Gynecol , 2007, 110(4):941-56. [PubMed 17906043 ] Bacon BR, Gordon SC, Lawitz E, et al, “Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection,” N Engl J Med , 201, 364(13):1207-17. [PubMed 21449784 ] Berman K and Kwo PY, “Boceprevir, an NS3 Protease Inhibitor of HCV,” Clin Liver Dis , 2009, 13(3):429-39. [PubMed 19628159 ] Centers for Disease Control and Prevention (CDC), "Sexually Transmitted Diseases Treatment Guidelines, 2010," MMWR Recomm Rep , 2010, 59(RR-12):1-110. [PubMed 21160459 ] Dienstag JL and McHutchinson JG, “American Gastroenterological Association Medical Position Statement on the Management of Hepatitis C,” Gastroenterology , 2006, 130(1):225-30. [PubMed 16401485 ] Ghany MG, Nelson DR, Strader DB, et al, “An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases,” Hepatology , 2011, 54(4):1433-44. [PubMed 21898493 ] Ghany MG, Strader DB, Thomas DL, et al, “Diagnosis, Management And Treatment Of Hepatitis C: An Update,” Hepatology , 2009, 49(4):1335-74. [PubMed 19330875 ] Ghosal A, Yuan Y, Tong W, et al, “Characterization of Human Liver Enzymes Involved in the Biotransformation of Boceprevir, a Hepatitis C Virus Protease Inhibitor,” Drug Metab Disposition , 2011, 39(3):510-21. [PubMed 21123164 ] Hoofnagle JH and Seeff LB,”Peginterferon and Ribavirin for Chronic Hepatitis C,” N Engl J Med , 2006, 355(23):2444-51. [PubMed 17151366 ] Kwo PY, Lawitz EJ, McCone J, et al, “Efficacy of Boceprevir, an NS3 Protease Inhibitor, in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Genotype 1 Hepatitis C Infection (SPRINT-1): An Open-Label, Randomised, Multicentre Phase 2 Trial,” Lancet , 2010, 376(9742):705-16. [PubMed 20692693 ] Lauer GM and Walker BD, “Hepatitis C Virus Infection,” N Engl J Med , 2001, 345(1):41-52. [PubMed 11439948 ] Poordad F, McCone J Jr, Bacon BR, et al, “Boceprevir for Untreated Chronic HCV Genotype 1 Infection,” N Engl J Med , 2011, 364(13):1195-206. [PubMed 21449783 ] Susser S, Welsch C, Wang Y, et al, “Characterization of Resistance to the Protease Inhibitor Boceprevir in Hepatitis C Virus-Infected Patients,” Hepatology , 2009, 50(6):1709-18. [PubMed 19787809 ] Topic 16492 Version 35.0

Poordad F, McCone J Jr, Bacon BR, et al, “Boceprevir for Untreated Chronic HCV Genotype 1 Infection,” N Engl J Med , 2011, 364(13):1195-206. [PubMed 21449783 ] Susser S, Welsch C, Wang Y, et al, “Characterization of Resistance to the Protease Inhibitor Boceprevir in Hepatitis C Virus-Infected Patients,” Hepatology , 2009, 50(6):1709-18. [PubMed 19787809 ] Topic 16492 Version 35.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0604-61.55.141.10-0AA24E0359-S244013.14]